SEC Filings

Hero overlay Cancer research Analyst Coverage Annual Report Proxy Materials Corporate Governance Events Presentations Financial Information Investor Disclaimer Press Releases Stock Information
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
S-8 POS

Post-effective amendment to an S-8 filing

View HTML
S-8 POS

Post-effective amendment to an S-8 filing

View HTML
S-8 POS

Post-effective amendment to an S-8 filing

View HTML
S-8 POS

Post-effective amendment to an S-8 filing

View HTML

Data provided by Kaleidoscope.

Investor Contact

Pacific Biosciences of California, Inc.
1305 O’Brien Drive, Menlo Park, CA 94025
ir@pacb.com